PIK3CA and PTEN mutations as drivers of osimertinib resistance in patients with NSCLC. Ursula Grazini, Daniel J. O'Neill, Matthew Martin, Chintia Xu,Nicolas Floch, Paul D. Smith, Emanuela CuomoCANCER RESEARCH（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
